Back to Search
Start Over
Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant.
- Source :
- Allergy; Dec2006, Vol. 61 Issue 12, p1490-1492, 3p, 2 Color Photographs, 1 Chart
- Publication Year :
- 2006
-
Abstract
- The article features icatibant in the pharmacotheraphy of acute hereditary angioedema (HAE). Icatibant is a selective bradykinin B<subscript>2</subscript>-receptor antagonist, effective in treating HAE. Acute attacks of HAE are often treated with oral tranexamic acid and administered by C1-esterase inhibitor. Information on a patient with HAE type 1, experienced several recurrent angiodema attacks and treated with icatibant is provided.
- Subjects :
- DRUG therapy
BRADYKININ
ESTERASES
ANGIONEUROTIC edema
PATIENTS
THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 01054538
- Volume :
- 61
- Issue :
- 12
- Database :
- Complementary Index
- Journal :
- Allergy
- Publication Type :
- Academic Journal
- Accession number :
- 22911368
- Full Text :
- https://doi.org/10.1111/j.1398-9995.2006.01197.x